Endometriosis: Molecular Pathophysiology and Recent Treatment Strategies—Comprehensive Literature Review
Open Access
- 24 June 2024
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (7) , 827
Abstract
Endometriosis is an enigmatic disease, with no specific cause or trigger yet discovered. Major factors that may contribute to endometriosis in the pelvic region include environmental, epigenetic, and inflammatory factors. Most experts believe that the primary mechanism behind the formation of endometrial lesions is associated with Sampson’s theory of “retrograde menstruation”. This theory suggests that endometrial cells flow backward into the peritoneal cavity, leading to the development of endometrial lesions. Since this specific mechanism is also observed in healthy women, additional factors may be associated with the formation of endometrial lesions. Current treatment options primarily consist of medical or surgical therapies. To date, none of the available medical therapies have proven effective in curing the disorder, and symptoms tend to recur once medications are discontinued. Therefore, there is a need to explore and develop novel biomedical targets aimed at the cellular and molecular mechanisms responsible for endometriosis growth. This article discusses a recent molecular pathophysiology associated with the formation and progression of endometriosis. Furthermore, the article summarizes the most current medications and surgical strategies currently under investigation for the treatment of endometriosis.Keywords
This publication has 111 references indexed in Scilit:
- Strengths and limitations of diagnostic tools for endometriosis and relevance in diagnostic test accuracy researchUltrasound in Obstetrics & Gynecology, 2022
- Evaluation and application of tools for the identification of known microRNAs in plantsApplications in Plant Sciences, 2021
- Accurate diagnosis of endometriosis using serum microRNAsAmerican Journal of Obstetrics and Gynecology, 2020
- Association between endometriosis and gynecological cancers: a critical review of the literatureArchives of Gynecology and Obstetrics, 2020
- Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction PotentialClinical Pharmacokinetics, 2018
- Diagnostic accuracy of serum miR‐122 and miR‐199a in women with endometriosisInternational Journal of Gynecology & Obstetrics, 2017
- Prognostic factors for assisted reproductive technology in women with endometriosis-related infertilityAmerican Journal of Obstetrics and Gynecology, 2017
- Estradiol Is a Critical Mediator of Macrophage-Nerve Cross Talk in Peritoneal EndometriosisThe American Journal of Pathology, 2015
- Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysisArchives of Gynecology and Obstetrics, 2014
- miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosisThe Journal of Pathology, 2013